42 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Stearns-Reider KM, Hicks MR, Hammond KG, Reynolds JC, Maity A, Kurmangaliyev YZ, Chin J, Stieg AZ, Geisse NA, Hohlbauch S, Kaemmer S, Schmitt LR, Pham TT, Yamauchi K, Novitch BG, ... ... Crosbie RH, et al. Myoscaffolds reveal laminin scarring is detrimental for stem cell function while sarcospan induces compensatory fibrosis. Npj Regenerative Medicine. 8: 16. PMID 36922514 DOI: 10.1038/s41536-023-00287-2  0.351
2023 McCourt JL, Stearns-Reider KM, Mamsa H, Kannan P, Afsharinia MH, Shu C, Gibbs EM, Shin KM, Kurmangaliyev YZ, Schmitt LR, Hansen KC, Crosbie RH. Multi-omics analysis of sarcospan overexpression in mdx skeletal muscle reveals compensatory remodeling of cytoskeleton-matrix interactions that promote mechanotransduction pathways. Skeletal Muscle. 13: 1. PMID 36609344 DOI: 10.1186/s13395-022-00311-x  0.453
2021 Mamsa H, Stark RL, Shin KM, Beedle AM, Crosbie RH. Sarcospan increases laminin binding capacity of α-dystroglycan to ameliorate DMD independent of Galgt2. Human Molecular Genetics. PMID 34581784 DOI: 10.1093/hmg/ddab276  0.41
2021 Gibbs EM, McCourt JL, Shin KM, Hammond KG, Marshall JL, Crosbie RH. Loss of sarcospan exacerbates pathology in mdx mice, but does not affect utrophin amelioration of disease. Human Molecular Genetics. PMID 33432327 DOI: 10.1093/hmg/ddaa264  0.767
2021 Gibbs EM, McCourt JL, Shin KM, Hammond KG, Marshall JL, Crosbie RH. Loss of sarcospan exacerbates pathology in mdx mice, but does not affect utrophin amelioration of disease. Human Molecular Genetics. PMID 33432327 DOI: 10.1093/hmg/ddaa264  0.767
2020 Shu C, Parfenova L, Mokhonova E, Collado JR, Damoiseaux R, Campagna J, John V, Crosbie RH. High-throughput screening identifies modulators of sarcospan that stabilize muscle cells and exhibit activity in the mouse model of Duchenne muscular dystrophy. Skeletal Muscle. 10: 26. PMID 32948250 DOI: 10.1186/S13395-020-00244-3  0.529
2020 Moore TM, Lin AJ, Strumwasser AR, Cory K, Whitney K, Ho T, Ho T, Lee JL, Rucker DH, Nguyen CQ, Yackly A, Mahata SK, Wanagat J, Stiles L, Turcotte LP, ... Crosbie RH, et al. Mitochondrial Dysfunction Is an Early Consequence of Partial or Complete Dystrophin Loss in Mice. Frontiers in Physiology. 11: 690. PMID 32636760 DOI: 10.3389/Fphys.2020.00690  0.382
2020 Lee CC, Hoang A, Segovia D, Herbst A, Barthelemy F, Gibbs E, Crosbie R, Nelson SF, Miceli C, Wanagat J. Enhanced Methods for Needle Biopsy and Cryopreservation of Skeletal Muscle in Older Adults. Journal of Cytology & Histology. 11. PMID 32566369 DOI: 10.37421/Jch.2020.11.553  0.397
2019 Shu C, Kaxon-Rupp AN, Collado JR, Damoiseaux R, Crosbie RH. Development of a high-throughput screen to identify small molecule enhancers of sarcospan for the treatment of Duchenne muscular dystrophy. Skeletal Muscle. 9: 32. PMID 31831063 DOI: 10.1186/S13395-019-0218-X  0.478
2019 Gibbs EM, Barthélémy F, Douine ED, Hardiman NC, Shieh PB, Khanlou N, Crosbie RH, Nelson SF, Miceli MC. Large in-frame 5' deletions in DMD associated with mild Duchenne muscular dystrophy: Two case reports and a review of the literature. Neuromuscular Disorders : Nmd. PMID 31672265 DOI: 10.1016/J.Nmd.2019.09.009  0.472
2019 Kramerova I, Kumagai-Cresse C, Ermolova N, Mokhonova E, Marinov M, Capote J, Becerra D, Quattrocelli M, Crosbie RH, Welch E, McNally EM, Spencer MJ. Spp1 (osteopontin) promotes TGFβ processing in fibroblasts of dystrophin deficient muscles through matrix metalloproteinases. Human Molecular Genetics. PMID 31411676 DOI: 10.1093/Hmg/Ddz181  0.461
2019 Parvatiyar MS, Brownstein AJ, Kanashiro-Takeuchi RM, Collado JR, Dieseldorff Jones KM, Gopal J, Hammond KG, Marshall JL, Ferrel A, Beedle AM, Chamberlain JS, Pinto JR, Crosbie RH. Stabilization of the cardiac sarcolemma by sarcospan rescues DMD-associated cardiomyopathy. Jci Insight. 5. PMID 31039133 DOI: 10.1172/Jci.Insight.123855  0.765
2011 Kim MH, Kay DI, Rudra RT, Chen BM, Hsu N, Izumiya Y, Martinez L, Spencer MJ, Walsh K, Grinnell AD, Crosbie RH. Myogenic Akt signaling attenuates muscular degeneration, promotes myofiber regeneration and improves muscle function in dystrophin-deficient mdx mice. Human Molecular Genetics. 20: 1324-38. PMID 21245083 DOI: 10.1093/Hmg/Ddr015  0.544
2011 Merveille AC, Davis EE, Becker-Heck A, Legendre M, Amirav I, Bataille G, Belmont J, Beydon N, Billen F, Clément A, Clercx C, Coste A, Crosbie R, de Blic J, Deleuze S, et al. CCDC39 is required for assembly of inner dynein arms and the dynein regulatory complex and for normal ciliary motility in humans and dogs. Nature Genetics. 43: 72-8. PMID 21131972 DOI: 10.1038/Ng.726  0.38
2010 Solares-Pérez A, Alvarez R, Crosbie RH, Vega-Moreno J, Medina-Monares J, Estrada FJ, Ortega A, Coral-Vazquez R. Altered calcium pump and secondary deficiency of gamma-sarcoglycan and microspan in sarcoplasmic reticulum membranes isolated from delta-sarcoglycan knockout mice. Cell Calcium. 48: 28-36. PMID 20638123 DOI: 10.1016/J.Ceca.2010.06.003  0.513
2009 Nelson SF, Crosbie RH, Miceli MC, Spencer MJ. Emerging genetic therapies to treat Duchenne muscular dystrophy. Current Opinion in Neurology. 22: 532-8. PMID 19745732 DOI: 10.1097/Wco.0B013E32832Fd487  0.374
2009 Peter AK, Ko CY, Kim MH, Hsu N, Ouchi N, Rhie S, Izumiya Y, Zeng L, Walsh K, Crosbie RH. Myogenic Akt signaling upregulates the utrophin-glycoprotein complex and promotes sarcolemma stability in muscular dystrophy. Human Molecular Genetics. 18: 318-27. PMID 18986978 DOI: 10.1093/Hmg/Ddn358  0.761
2008 Peter AK, Marshall JL, Crosbie RH. Sarcospan reduces dystrophic pathology: stabilization of the utrophin-glycoprotein complex. The Journal of Cell Biology. 183: 419-27. PMID 18981229 DOI: 10.1083/Jcb.200808027  0.783
2007 Bekker JM, Colantonio JR, Stephens AD, Clarke WT, King SJ, Hill KL, Crosbie RH. Direct interaction of Gas11 with microtubules: implications for the dynein regulatory complex. Cell Motility and the Cytoskeleton. 64: 461-73. PMID 17366626 DOI: 10.1002/Cm.20196  0.705
2007 Peter AK, Miller G, Crosbie RH. Disrupted mechanical stability of the dystrophin-glycoprotein complex causes severe muscular dystrophy in sarcospan transgenic mice. Journal of Cell Science. 120: 996-1008. PMID 17311848 DOI: 10.1242/Jcs.03360  0.788
2007 Miller G, Wang EL, Nassar KL, Peter AK, Crosbie RH. Structural and functional analysis of the sarcoglycan-sarcospan subcomplex. Experimental Cell Research. 313: 639-51. PMID 17223103 DOI: 10.1016/J.Yexcr.2006.11.021  0.742
2006 Miller G, Peter AK, Espinoza E, Heighway J, Crosbie RH. Over-expression of Microspan, a novel component of the sarcoplasmic reticulum, causes severe muscle pathology with triad abnormalities. Journal of Muscle Research and Cell Motility. 27: 545-58. PMID 16823602 DOI: 10.1007/S10974-006-9069-2  0.763
2006 Peter AK, Crosbie RH. Hypertrophic response of Duchenne and limb-girdle muscular dystrophies is associated with activation of Akt pathway. Experimental Cell Research. 312: 2580-91. PMID 16797529 DOI: 10.1016/J.Yexcr.2006.04.024  0.737
2006 Colantonio JR, Bekker JM, Kim SJ, Morrissey KM, Crosbie RH, Hill KL. Expanding the role of the dynein regulatory complex to non-axonemal functions: association of GAS11 with the Golgi apparatus. Traffic (Copenhagen, Denmark). 7: 538-48. PMID 16643277 DOI: 10.1111/J.1600-0854.2006.00411.X  0.73
2003 Yi CE, Bekker JM, Miller G, Hill KL, Crosbie RH. Specific and potent RNA interference in terminally differentiated myotubes. The Journal of Biological Chemistry. 278: 934-9. PMID 12421826 DOI: 10.1074/Jbc.M205946200  0.727
2002 Crosbie RH, Barresi R, Campbell KP. Loss of sarcolemma nNOS in sarcoglycan-deficient muscle. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 16: 1786-91. PMID 12409321 DOI: 10.1096/Fj.02-0519Com  0.67
2002 Crosbie RH, Dovico SA, Flanagan JD, Chamberlain JS, Ownby CL, Campbell KP. Characterization of aquaporin-4 in muscle and muscular dystrophy. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 16: 943-9. PMID 12087055 DOI: 10.1096/Fj.01-0327Com  0.659
2001 Crosbie RH. NO vascular control in Duchenne muscular dystrophy. Nature Medicine. 7: 27-9. PMID 11135610 DOI: 10.1038/83309  0.462
2000 Crawford GE, Faulkner JA, Crosbie RH, Campbell KP, Froehner SC, Chamberlain JS. Assembly of the dystrophin-associated protein complex does not require the dystrophin COOH-terminal domain. The Journal of Cell Biology. 150: 1399-410. PMID 10995444 DOI: 10.1083/Jcb.150.6.1399  0.626
2000 Crosbie RH, Lim LE, Moore SA, Hirano M, Hays AP, Maybaum SW, Collin H, Dovico SA, Stolle CA, Fardeau M, Tomé FM, Campbell KP. Molecular and genetic characterization of sarcospan: insights into sarcoglycan-sarcospan interactions. Human Molecular Genetics. 9: 2019-27. PMID 10942431 DOI: 10.1093/Hmg/9.13.2019  0.749
2000 Holt KH, Crosbie RH, Venzke DP, Campbell KP. Biosynthesis of dystroglycan: processing of a precursor propeptide. Febs Letters. 468: 79-83. PMID 10683445 DOI: 10.1016/S0014-5793(00)01195-9  0.476
1999 Crosbie RH, Lebakken CS, Holt KH, Venzke DP, Straub V, Lee JC, Grady RM, Chamberlain JS, Sanes JR, Campbell KP. Membrane targeting and stabilization of sarcospan is mediated by the sarcoglycan subcomplex. The Journal of Cell Biology. 145: 153-65. PMID 10189375 DOI: 10.1083/Jcb.145.1.153  0.659
1998 Duclos F, Straub V, Moore SA, Venzke DP, Hrstka RF, Crosbie RH, Durbeej M, Lebakken CS, Ettinger AJ, van der Meulen J, Holt KH, Lim LE, Sanes JR, Davidson BL, Faulkner JA, et al. Progressive muscular dystrophy in alpha-sarcoglycan-deficient mice. The Journal of Cell Biology. 142: 1461-71. PMID 9744877 DOI: 10.1083/Jcb.142.6.1461  0.755
1998 Crosbie RH, Yamada H, Venzke DP, Lisanti MP, Campbell KP. Caveolin-3 is not an integral component of the dystrophin glycoprotein complex. Febs Letters. 427: 279-82. PMID 9607328 DOI: 10.1016/S0014-5793(98)00442-6  0.614
1998 Crosbie RH, Straub V, Yun HY, Lee JC, Rafael JA, Chamberlain JS, Dawson VL, Dawson TM, Campbell KP. mdx muscle pathology is independent of nNOS perturbation. Human Molecular Genetics. 7: 823-9. PMID 9536086 DOI: 10.1093/Hmg/7.5.823  0.618
1997 Crosbie RH, Heighway J, Venzke DP, Lee JC, Campbell KP. Sarcospan, the 25-kDa transmembrane component of the dystrophin-glycoprotein complex. The Journal of Biological Chemistry. 272: 31221-4. PMID 9395445 DOI: 10.1074/Jbc.272.50.31221  0.633
1997 Crosbie RH, Straub V, Vnzke DP, Yun HY, Chamberlain JS, Dawson VL, Dawson TM, Campbell KP. Dystrophin and nnos double knockout mice maintain dystrophic phenotype Faseb Journal. 11: A1417.  0.403
1996 Campbell KP, Crosbie RH. Muscular dystrophy. Utrophin to the rescue. Nature. 384: 308-9. PMID 8934508 DOI: 10.1038/384308A0  0.6
1995 Crosbie RH, Chalovich JM, Reisler E. Flexation of caldesmon: effect of conformation on the properties of caldesmon. Journal of Muscle Research and Cell Motility. 16: 509-18. PMID 8567938 DOI: 10.1007/Bf00126435  0.586
1994 Crosbie RH, Miller C, Chalovich JM, Rubenstein PA, Reisler E. Caldesmon, N-terminal yeast actin mutants, and the regulation of actomyosin interactions. Biochemistry. 33: 3210-6. PMID 8136356 DOI: 10.1021/Bi00177A010  0.592
1994 Crosbie RH, Miller C, Cheung P, Goodnight T, Muhlrad A, Reisler E. Structural connectivity in actin: effect of C-terminal modifications on the properties of actin. Biophysical Journal. 67: 1957-64. PMID 7858132 DOI: 10.1016/S0006-3495(94)80678-2  0.555
1992 Crosbie RH, Chalovich JM, Reisler E. Interaction of caldesmon and myosin subfragment 1 with the C-terminus of actin Biochemical and Biophysical Research Communications. 184: 239-245. PMID 1567431 DOI: 10.1016/0006-291X(92)91184-R  0.533
Show low-probability matches.